Rejected at 8:51 p.m. Mar, 04, 2024 ] by thomas.holmes
Author: vpinkert
Related Note: 1520444298927
Rationale for change

Including the long hand to accompany the acronym because it helps for learning what the acronyms are.

Rejection reason

This is a very common acronym which is also used in practice questions, if you can't remember it then write it in extra until you learn it

Text Text
Extra
- Products of inflammation (e.g., fibrinogen) coat RBCs and cause aggregation; the denser RBC aggregates fall at a faster rate within a pipette tube

- ESR is often co-tested with CRP levels
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy

Watch Antiplatelet Agents
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::04_Pathology::02_Inflammation::02_Acute_phase_reactants::*Fibrinogen #AK_Step1_v12::^Other::^EXPN::BGadd #AK_Step1_v12::#Pathoma::01_Growth_Adaptations::BGadds #AK_Step1_v12::#FirstAid::04_Pathology::02_Inflammation::03_Erythrocyte_sedimentation_rate #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::03_Antiplatelet_agents #AK_Step1_v12::#UWorld::COMLEX::24910 #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Pathoma_Chapter_1_(Cell_Injury,_Death) #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step2_v12::#B&B::09_MSK::01_General::08_Muscle_Disorders::Extra !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Immunology+General-Pathology::Pathoma-Chapter-1-(Cell-Injury,Death) #AK_Step1_v12::#AMBOSS::cTaapP #AK_Step1_v12::#UWorld::Step::1801 #AK_Step1_v12::#OME_banner::Basic_Science::13_Hematology_Oncology::11_Hemostasis #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#B&B::16_Pathology::01_General::06_Inflammation_Principles